MapLight Therapeutics MPLT
NASDAQ MPLT
$13.85 +0.71 (+5.44%)
As of: Sep 4, 2026 · 1:39 PM EDT

MapLight Therapeutics (MPLT) Interest & Investment Income (2024 - 2026)

MapLight Therapeutics (MPLT) posted Interest & Investment Income of $2.5 million for Q4 2025, up 59.46% sequentially from $1.5 million in Q3 2025, and up 174.75% YoY from $899000.0 in Q4 2024.

Analysis

MapLight Therapeutics (MPLT) Interest & Investment Income (2024 - 2026) Analysis & Trends

MapLight Therapeutics has reported Interest & Investment Income for 2 years, with the latest figure at $2.5 million in Q4 2025.

  • Quarterly Interest & Investment Income rose 174.75% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (changed N/A YoY) and the FY2025 annual result came in at $5.5 million, up 22.51% from the prior year.
  • Interest & Investment Income advanced to $2.5 million in Q4 2025 per MPLT's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $2.5 million in Q4 2025 and troughed at $899000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 5.13 Mn
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 10.98 Mn
10 MapLight Therapeutics 629.45 Mn 629.45 Mn - 2.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.35 Mn
Dec 31, 2025 2.47 Mn
Sep 30, 2025 1.55 Mn
Jun 30, 2025 688,000.00
Dec 31, 2024 899,000.00
Sep 30, 2024 1.08 Mn